Article Versions Notes

Biagi F, Carlomagno F, Carbone M, Veralli R, Vespasiani-Gentilucci U, Riva E, Manfrini S, Tuccinardi D, De Santis A, Gnessi L, et al. Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication. Metabolites. 2023; 13(11):1119. https://doi.org/10.3390/metabo13111119

Biagi, Filippo, Francesco Carlomagno, Martina Carbone, Roberta Veralli, Umberto Vespasiani-Gentilucci, Elisabetta Riva, Silvia Manfrini, Dario Tuccinardi, Adriano De Santis, Lucio Gnessi, and et al. 2023. "Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication" Metabolites 13, no. 11: 1119. https://doi.org/10.3390/metabo13111119

Biagi, F., Carlomagno, F., Carbone, M., Veralli, R., Vespasiani-Gentilucci, U., Riva, E., Manfrini, S., Tuccinardi, D., De Santis, A., Gnessi, L., & Watanabe, M. (2023). Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication. Metabolites, 13(11), 1119. https://doi.org/10.3390/metabo13111119